Ashok Kumar Balaraman
Overview
Explore the profile of Ashok Kumar Balaraman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bushi G, Balaraman A, Gaidhane S, Ballal S, Kumar S, Bhat M, et al.
Brain Behav Immun Health
. 2025 Jan;
43:100931.
PMID: 39867846
Background And Objective: Lyme disease, caused by , presents major health challenges worldwide, leading to serious neurological and musculoskeletal issues that impact patients' lives and healthcare systems. This systematic review...
12.
Hussain M, Mujwar S, Babu M, Goyal K, Chellappan D, Negi P, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Jan;
PMID: 39862263
As a promising candidate for tackling drug-resistant cancers, triptolide, a diterpenoid derived from the Chinese medicinal plant Tripterygium wilfordii, has been developed. This review summarizes potential antitumor activities, including the...
13.
Balaraman A, Altamimi A, Babu M, Goyal K, Padmapriya G, Bansal P, et al.
Biogerontology
. 2025 Jan;
26(1):46.
PMID: 39832057
Aging is associated with a marked increase in cardiovascular diseases, such as myocardial infarction (MI). Cellular senescence is also a crucial factor in the development of age-related MI. Matrix metalloproteinases...
14.
Akashanand A, Akashanand , Khatib M, Balaraman A, Roopashree R, R R, et al.
J Asthma
. 2025 Jan;
:1-12.
PMID: 39817407
Objective: Asthma poses a significant health burden in South Asia, with increasing incidence and mortality despite a global decline in age-standardized prevalence rates. This study aims to analyze asthma trends...
15.
Mehta R, Balaraman A, Sah S, Bushi G
Nutr Metab Cardiovasc Dis
. 2025 Jan;
103816.
PMID: 39800621
No abstract available.
16.
Soni M, Balaraman A, Rai N
J Infect Prev
. 2024 Dec;
:17571774241309800.
PMID: 39726940
No abstract available.
17.
Mehta R, Balaraman A, Shabil M, Sah S
J Cachexia Sarcopenia Muscle
. 2024 Dec;
16(1):e13679.
PMID: 39710948
No abstract available.
18.
Balaraman A, Babu M, Moglad E, Mandaliya V, Rekha M, Gupta S, et al.
Pathol Res Pract
. 2024 Dec;
266:155785.
PMID: 39708520
Several molecular strategies based on targeted gene delivery systems have been developed in recent years; however, the CRISPR-Cas9 technology introduced a new era of targeted gene editing, precisely modifying oncogenes,...
19.
Shabil M, Khatib M, Ballal S, Bansal P, Tomar B, Ashraf A, et al.
J Med Virol
. 2024 Dec;
96(12):e70122.
PMID: 39707867
Mpox, formerly known as monkeypox, has re-emerged as a significant global health concern, particularly during the widespread outbreak of 2022. As an orthopoxvirus related to the eradicated smallpox virus, mpox...
20.
Balaraman A, Moglad E, Afzal M, Babu M, Goyal K, Roopashree R, et al.
Clin Chim Acta
. 2024 Dec;
567():120105.
PMID: 39706249
Pancreatic cancer is a highly fatal malignancy due to poor early detection rate and resistance to conventional therapies. This review examines the potential for liquid biopsy as a transformative technology...